Biocan novel respi nasal drops, lyophilisate and solvent for suspension for dogs
To reduce clinical signs and bacterial excretion after infection with Bordetella bronchiseptica and to reduce clinical signs and viral excretion after infection with canine parainfluenza virus.
Statement of the active substances and other ingredients
Each dose of 0.5 ml contains:
Active substances:
Live attenuated Bordetella bronchiseptica strain MSLB 3096 108.0–109.8 CFU*
Live attenuated Canine parainfluenza Type 2 virus, strain CPiV-2 Bio 15 103.5–105.8 CCID50**
*CFU: Colony forming unit
**CCID50: Cell culture infectious dose 50%
Solvent:
Water for injections (WFI) 0.5 ml
Lyophilisate: spongy matter of whitish to yellowish colour.
Solvent: clear colourless liquid.
Indications
Active immunisation of dogs from 3 weeks of age:
- to reduce clinical signs and bacterial excretion after infection with Bordetella bronchiseptica and
- to reduce clinical signs and viral excretion after infection with canine parainfluenza virus.
Onset of immunity:
3 days after primary vaccination for Bordetella bronchiseptica.
7 days after primary vaccination for canine parainfluenza virus.
Duration of immunity:
1 year.
Target species
Dogs.
Bioveta